TurnerTrends Stock Rating Report for AMLN
Data valid for week beginning July 21, 2008
|
AMLN [News]
|
Amylin Pharmaceuticals Inc
|
Company Profile
"Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for diabetes, obesity, and other diseases in the United States. It sells BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection for the treatment of patients with Type II diabetes. The company also has research and development programs in the therapeutic areas of diabetes and obesity, including exenatide once weekly- Nasal Exenatide, a nasal spray formulation of exenatide for diabetes- Pramlintide and PYY 3-36 for the treatment of obesity- Leptin for the treatment of obesity and lipodystrophy- Pramlintide-Metreleptin combination product candidate for overweight or obese subjects- and second generation Amylinomimetic for weight loss. It sells its products to healthcare providers, managed healthcare organizations, wholesalers and pharmacies, government purchasers, and other third-party payors. The company has collaboration agreements with Eli Lilly and Company, as well as with Alkermes, Inc. to develop exenatide once weekly for diabetes- a contract research arrangement with Kelaroo, Inc. for the commercialization of Kelaroo's SeqR technology that is used for peptide hormone identification and optimization- a joint research collaboration agreement with BioSeek, Inc. for discovery and development of novel peptide therapeutics for inflammatory conditions- and a joint research collaboration agreement with Xenome, Ltd. for discovery and development of novel peptide hormones for a range of metabolic and musculoskeletal diseases. It also has a collaboration with Pacira Pharmaceuticals, Inc. for the development of sustained release injectable products based on the DepoFoam technology platform. Amylin Pharmaceuticals was founded in 1987 and is based in San Diego, California."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
|
|
Latest News
| Tue, 22 Jul 2008 23:36:09 Etc/GMT | Fast Money 'Pops and Drops': SanDisk (at TheStreet.com) | | Tue, 22 Jul 2008 22:43:15 Etc/GMT | Pops & Drops: UPS, Vodaphone... (at CNBC) | | Tue, 22 Jul 2008 21:31:00 Etc/GMT | [video] Stock Pops & Drops (at CNBC) | | Tue, 22 Jul 2008 20:27:19 Etc/GMT | Anemic Amylin's Signs of Recovery (at Motley Fool) | | Tue, 22 Jul 2008 16:26:48 Etc/GMT | CORRECTED - UPDATE - Amylin posts wider second-quarter net loss (at Reuters) | | Tue, 22 Jul 2008 14:15:10 Etc/GMT | UPDATE - Goldman Sachs adds Amylin to conviction buy list (at Reuters) | | Tue, 22 Jul 2008 13:21:53 Etc/GMT | New Star Analyst Rankings for AMYLIN PHARMA INC (StarMine) | | Tue, 22 Jul 2008 11:19:27 Etc/GMT | Wall Street Breakfast: Must-Know News (at Seeking Alpha) | | Tue, 22 Jul 2008 09:53:06 Etc/GMT | Roche's Genentech Offer Sends Ripples Through Biotech (at Seeking Alpha) | | Tue, 22 Jul 2008 03:20:29 Etc/GMT | Amylin Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript (at Seeking Alpha) | | Mon, 21 Jul 2008 22:52:32 Etc/GMT | UPDATE - Amylin posts wider second-quarter net loss (at Reuters) | | Mon, 21 Jul 2008 21:27:28 Etc/GMT | Amylin affirms 2008 product sales outlook (at Reuters) | | Mon, 21 Jul 2008 21:00:00 Etc/GMT | Amylin Pharmaceuticals, Inc. Earnings Call scheduled for 5:00 pm ET today (CCBN) | | Mon, 21 Jul 2008 20:15:48 Etc/GMT | AMYLIN PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (EDGAR Online) | | Mon, 21 Jul 2008 20:05:00 Etc/GMT | Amylin Pharmaceuticals Reports Second Quarter Financial Results (PR Newswire) | | Mon, 21 Jul 2008 19:23:00 Etc/GMT | [video] Fast Money Final Call (at CNBC) | | Mon, 21 Jul 2008 16:56:40 Etc/GMT | Roche Offer For Genentech Sends Ripples Through Biotech (at CNBC) | | Mon, 21 Jul 2008 15:42:39 Etc/GMT | Sector Snap: Biotech stocks rise on buyout offer (AP) | | Mon, 21 Jul 2008 11:07:07 Etc/GMT | Q2 2008 Amylin Pharmaceuticals, Inc. Earnings Release - After Market Close (CCBN) | | Tue, 15 Jul 2008 20:05:00 Etc/GMT | Amylin Pharmaceuticals to Webcast Second Quarter Results (PR Newswire) | News provided by Yahoo! Finance |
|
